Perinatal Exposure to Low-Dose Bisphenol-A Disrupts the Structural and Functional Development of the Hypothalamic

Harry MacKay1, Zachary R Patterson1, Alfonso Abizaid1

  • 1Department of Neuroscience, Carleton University, Ottawa, Ontario, Canada.

Endocrinology
|March 22, 2017
PubMed

Insights

Exposure to Bisphenol-A (BPA) during development alters hypothalamic circuitry, leading to leptin resistance and potential obesity. This endocrine disruptor may permanently affect metabolic homeostasis by programming the brain.

Area of Science:

  • Endocrinology
  • Neurobiology
  • Toxicology

Background:

  • Bisphenol-A (BPA) is an endocrine disruptor found in plastics, with known estrogenic activity.
  • Previous studies linked BPA to disrupted feeding circuitry and leptin sensitivity in adult obese mice.
  • The impact of BPA on metabolic regulation before obesity onset remained unclear.

Purpose of the Study:

  • To investigate the effects of developmental Bisphenol-A (BPA) exposure on leptin sensitivity and hypothalamic structure in young mice before obesity onset.
  • To determine if BPA exposure causes a pre-existing phenotype impacting metabolic homeostasis.
  • To explore the role of BPA in programming the hypothalamic melanocortin system.

Main Methods:

  • Pregnant and lactating mice were fed low, environmentally relevant doses of BPA or diethylstilbestrol (DES).
  • Offspring were studied for leptin sensitivity, including food intake suppression and body weight loss.
  • Hypothalamic neurobiology, specifically pro-opiomelanocortin (POMC) projections into the paraventricular nucleus (PVN), was analyzed.

Main Results:

  • Young adult BPA-exposed mice exhibited resistance to leptin's effects on food intake, body weight, and POMC upregulation.
  • Both male and female BPA-exposed mice showed reduced POMC projections into the PVN.
  • BPA and DES exposure altered postnatal leptin surges, with partial rescue of POMC projections in female BPA-exposed mice receiving leptin supplementation.

Conclusions:

  • Developmental exposure to Bisphenol-A (BPA) may permanently alter hypothalamic melanocortin circuitry.
  • BPA acts as a potential obesogen by programming neurobiology related to metabolic homeostasis.
  • These findings suggest BPA can induce a pre-existing phenotype impacting long-term metabolic health.

Related Concept Videos

Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
3.0K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.0K
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
903
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K